These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 801693)

  • 1. [Immunofluorescence examination of blood, clinically unchanged skin, and kidneys in systemic lupus erythematosus].
    Stefanović Z; Stefanović M; Arnerić S; Mijailović B
    Zb Vojnomed Akad; 1975; ():18-21. PubMed ID: 801693
    [No Abstract]   [Full Text] [Related]  

  • 2. [The direct immunofluorescence skin test in systemic lupus erythematosus. Correlation with the clinical stage of the disease, laboratory changes and nephropathy].
    dos Santos RF; Santiago MB; Yoshinari NH; Rodrigues CJ; Cossermelli W
    Rev Hosp Clin Fac Med Sao Paulo; 1988; 43(4):197-200. PubMed ID: 3074450
    [No Abstract]   [Full Text] [Related]  

  • 3. [Demonstration of antinuclear antibodies in the epidermis of patients with progressive systemic sclerosis, generalized lupus erythematosus and dermatomyositis].
    Lamas Robles C; Mejía Arreguín S; Orozco Medina JH; González Mendoza A
    Rev Invest Clin; 1984; 36(2):115-9. PubMed ID: 6385174
    [No Abstract]   [Full Text] [Related]  

  • 4. Systemic lupus erythematosus. Studies of the antibodies bound to skin.
    Landry M; Sams WM
    J Clin Invest; 1973 Aug; 52(8):1871-80. PubMed ID: 4578295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin immunofluorescence patterns in SLE patients in Singapore.
    Ratnam KV; Phay KL; Ng SK; Tan T
    Singapore Med J; 1987 Dec; 28(6):517-9. PubMed ID: 3327168
    [No Abstract]   [Full Text] [Related]  

  • 6. Epidermal nucleolar IgG deposition in clinically normal skin: clinical and serologic features of eight patients.
    Prystowsky SD; Gilliam JN; Tuffanelli DL
    Arch Dermatol; 1978 Apr; 114(4):536-8. PubMed ID: 348111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical significance of the in vivo antinuclear antibody phenomenon.
    Williams WV; Barjenbrach P; Adelstein E; Sharp GC; Walker SE
    Arch Pathol Lab Med; 1986 Sep; 110(9):798-802. PubMed ID: 3530186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunological diagnosis of lupus erythematosus].
    Sönnichsen N; Barthelmes H; Meffert H; Albrecht-Nebe H; Diezel W; Günther W
    Dermatol Monatsschr; 1979 Oct; 165(10):708-20. PubMed ID: 393545
    [No Abstract]   [Full Text] [Related]  

  • 9. A subset of antibodies from the sera of patients with systemic lupus erythematosus react with vimentin and DNA.
    Sánchez A; Ossorio C; Alvaro-Gracia JM; Padilla R; Avila J
    J Rheumatol; 1990 Feb; 17(2):205-9. PubMed ID: 1690805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methanol-fixed paraffin-embedded bovine and human epidermis for antinuclear antibodies.
    Guss SB; Ugel AR
    Arch Dermatol; 1972 Nov; 106(5):674-7. PubMed ID: 4564453
    [No Abstract]   [Full Text] [Related]  

  • 11. [Nucleolar, homogeneous and peripheral fluorescence of epidermal nuclei in direct immunofluorescence: 4 cases (author's transl)].
    Morel P; Allègre P; Civatte J
    Ann Dermatol Venereol; 1979 Apr; 106(4):361-4. PubMed ID: 384881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The use of autologous or normal skin and fluorescein-labelled anti-C3 serum to increase the sensitivity of immunofluorescence reaction to detect antinuclear antibodies [].
    Vázquez-Escobosa C; Gómez-Estrada H
    Rev Invest Clin; 1982; 34(2):125-8. PubMed ID: 6750732
    [No Abstract]   [Full Text] [Related]  

  • 13. The immunofluorescent "band" test for lupus erythematosus. 3. Employing clinically normal skin.
    Burnham TK; Fine G
    Arch Dermatol; 1971 Jan; 103(1):24-32. PubMed ID: 4099590
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antinuclear factors in systemic lupus erythematosus].
    Cossermelli W; Gomide WS; Pastor EM; Belliboni N; de Almeida TV
    AMB Rev Assoc Med Bras; 1978 Dec; 24(12):421-3. PubMed ID: 85319
    [No Abstract]   [Full Text] [Related]  

  • 15. Crithidia luciliae assay for antibodies to native DNA in procainamide-induced lupus erythematosus.
    Dixon JA; Mulhern LM; Whiteside TL; Luksick J
    J Rheumatol; 1980; 7(4):544-6. PubMed ID: 6999152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical studies on anti-nuclear factor in the patients with systemic lupus erythematosus concerning possible role on pathogenesis].
    Kurata N
    Rinsho Ketsueki; 1972 Aug; 13(4):527-34. PubMed ID: 4539473
    [No Abstract]   [Full Text] [Related]  

  • 17. [Human epidermis as a substrate for indirect immunofluorescence studies].
    Kleinhans D
    Z Haut Geschlechtskr; 1972 Dec; 47(24):981-5. PubMed ID: 4567848
    [No Abstract]   [Full Text] [Related]  

  • 18. Subepidermal deposition of immunoglobulin in NZB/NZW F hybrid mice.
    Gilliam JN; Hurd ER; Ziff M
    J Immunol; 1975 Jan; 114(1 Pt 1):133-7. PubMed ID: 1089709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bullous pemphigoid associated with systemic lupus erythematosus.
    Jordon RE; Muller SA; Hale WL; Beutner EH
    Arch Dermatol; 1969 Jan; 99(1):17-25. PubMed ID: 4178218
    [No Abstract]   [Full Text] [Related]  

  • 20. [Le cells in the "skin window" in patients with systemic lupus erythematosus].
    Kozlovskaia LV; Tareeva IE; Tuganbekova SK; Ianushkevich TN
    Ter Arkh; 1988; 60(7):88-90. PubMed ID: 2463694
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.